Hide Board Information

Show Board Information

Currenc Group Inc. CURR

Board Mod: Mauibound

Asst Mods:

Last Post: 07/02/2024 10:39:27 AM

Board Marks: 4

Posts Today: 0

Board Views Today: 23

Currenc Group Inc. (OTCMRKTS: CURR) Stock Message Board

1. CURR Company Profile

    

2. CURR Time & Sales

    

3. CURR Recent News

    

4. CURR Filings

    

5. CURR Financials

    

6. CURR Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

63	Cure Pharmaceutical Reports Second Quarter 2022 (1)	Lee Adams	09/02/2022 9:27:17 AM
62	CURE Pharmaceutical Announces Rob Davidson as new	Lee Adams	08/16/2022 9:06:34 AM
61	CURE Pharmaceutical Provided Full Corporate	Lee Adams	08/09/2022 9:08:41 AM
60	CURE Pharmaceutical Announces the Appointment of	Lee Adams	08/02/2022 9:20:07 AM
59	CURE Pharmaceutical Announces Teleconference (1)	Lee Adams	08/01/2022 9:33:14 AM
58	CURE Pharmaceutical Announces the Sale of a (1)	Lee Adams	07/28/2022 9:46:28 AM
57	CURE Pharmaceutical Announces Positive Findings	Lee Adams	05/12/2022 2:25:03 PM
56	$CURR presenting here: Keynotes, Educational	Lee Adams	04/27/2022 10:34:26 AM
55	$CURR News: Sera Labs Inc. Products Now Available	Lee Adams	04/14/2022 9:50:50 AM
54	CURE Pharmaceutical and Milagro Pharmaceuticals	Lee Adams	03/03/2022 11:44:16 AM
53	$CURR News: Sera Labs, a Subsidiary of CURE	Lee Adams	01/24/2022 9:29:28 AM
52	June 10, 2021 8:15 AM CURE Pharmaceutical Signs	Mauibound	06/19/2021 10:44:04 PM
51	Nicole Kidman and Sera Labs Inc., a CURE	Lee Adams	06/09/2021 10:33:48 AM
50	CURE Pharmaceutical Schedules Investor Webcast	Lee Adams	05/25/2021 10:03:43 AM
49	CURE Pharmaceutical First Quarter Revenue	Lee Adams	05/17/2021 9:42:14 AM
48	CURE Pharmaceutical Receives ISO Certification	Lee Adams	05/13/2021 10:43:37 AM
47	Nicole Kidman, Sera Labs Strategic Business	Lee Adams	04/28/2021 10:43:29 AM
46	CURE Pharmaceutical Announces Successful Results	Lee Adams	04/21/2021 9:57:31 AM
45	CURE Pharmaceutical to Present at the 2021	Lee Adams	04/19/2021 9:41:36 AM
44	Nicole Kidman, Sera Labs Strategic Business	Lee Adams	04/13/2021 10:10:30 AM
43	CURE Pharmaceutical Reports Increase in Revenue	Lee Adams	04/01/2021 9:49:45 AM
42	CURE Pharmaceutical Augments Its Existing U.S.	Lee Adams	03/23/2021 10:26:17 AM
41	CURE Pharmaceutical Launches Psychedelic Oral	Lee Adams	03/16/2021 10:03:50 AM
40	CURE Pharmaceutical Announces Addition of Two New	Lee Adams	03/10/2021 10:13:43 AM
39	CURE Pharmaceuticals Subsidiary Sera Labs	Lee Adams	03/03/2021 1:53:49 PM
38	CURE Pharmaceutical Announces the Initiation of	Lee Adams	02/23/2021 9:04:38 AM
37	CURE Pharmaceutical Announces Promotions and	Lee Adams	02/11/2021 9:42:16 AM
36	Sera Labs Unveils ImmunD an Important New	Lee Adams	02/10/2021 11:10:58 AM
35	CURE Pharmaceutical (Stock Symbol: CURR) is a	Lee Adams	02/05/2021 11:53:04 AM
34	CURE Pharmaceutical to Present at 2021 NobleCon17	Lee Adams	01/19/2021 9:42:07 AM
33	CURE Pharmaceutical to Present at H.C. Wainwright	Lee Adams	01/07/2021 9:53:46 AM
32	CURE Pharmaceutical Receives FDA Approval for its	Lee Adams	01/05/2021 9:17:55 AM
31	$CURR - Investor Video Webcast from December 17,	Lee Adams	12/23/2020 10:57:20 AM
30	CURR Form 4 Filed on Dec. 21st. CEO Robert	Lee Adams	12/21/2020 7:31:25 PM
29	CURE Pharmaceutical to Present at LD Micro on	Lee Adams	12/14/2020 12:32:19 PM
28	Nicole Kidman Partners With SeraLabs, a CURE	Lee Adams	12/08/2020 9:26:13 AM
27	CURR 32% v458K c1.64 f53,2M H2.12 S1.47	znewcar1	12/01/2020 10:47:07 PM
26	CURE Pharmaceutical Issues Letter to Shareholders	Lee Adams	11/18/2020 9:26:03 AM
25	$CURR CURE Pharmaceutical Closes $10 Million	stocksonhighalert	11/16/2020 12:48:57 PM
24	CURE Pharmaceutical to Present at Two Virtual	Lee Adams	09/02/2020 9:19:52 AM
23	Excellent video interview with SERA LABS CEO.	Lee Adams	08/27/2020 1:04:14 PM
22	CURR is starting to get more bio-industry	Lee Adams	08/21/2020 11:10:23 AM
21	$CURR News: CURE Pharmaceutical to Acquire Sera	trooperstocks	07/28/2020 9:01:58 AM
20	$CURR News: CURE Pharmaceutical CBD Oral Thin	trooperstocks	07/15/2020 8:13:34 AM
19	CURE Pharmaceutical Receives NSFs cGMP	Lee Adams	07/08/2020 9:29:23 AM
18	CURE Pharma's CEO, Rob Davidson, on Leveraging IP	Lee Adams	07/06/2020 10:38:27 AM
17	CURE Pharmaceutical Appoints Chief Business	Lee Adams	06/16/2020 9:31:07 AM
16	CURE Pharmaceutical Announces Exercise of	Lee Adams	06/09/2020 1:26:24 PM
15	CURE Pharmaceutical Expands to Mexico in	Lee Adams	06/03/2020 10:33:35 AM
14	At one time $AMBS was going to sell ELTO PHARMA	Mauibound	04/23/2020 2:27:13 AM

Newer

Older

Recent Articles

• GoldHaven's Strategic Acquisition Enhances Mining Portfolio
• Key Insights on TMC the Metals Company's Class Action Lawsuit
• EngageSmart Shareholders Urged to Act Before Critical Deadline
• Updates on Acadia Healthcare: What Investors Need to Know
• Class Action Alert for Toronto-Dominion Bank Shareholders
• VERSES AI Inc. Finalizes First Phase of LIFE Private Placement
• Lilium N.V. Faces Class Action Lawsuit Amid Financial Woes
• Franklin Resources, Inc. Investigated for Possible Securities Misconduct
• VERSES AI Inc. Expands Special Warrant Offering Plans
• CIIE Event Showcases Global Trade Opportunities and Vision
• CenterPoint Energy's Strategy to Alleviate Storm Cost for Customers
• Silver Star Properties Set for Annual Shareholder Meeting
• Investors Urged to Join Class Action Against Winnebago Industries
• Kaspi.kz Investors: Take Action on Potential Misleading Claims
• CenterPoint Energy Advances Resilience Initiatives for 2025
• Keg Royalties Fund Declares November Cash Distribution
• Shernoff Bidart Echeverria LLP Welcomes Veteran Lawyer Jerry Flanagan
• STAKING AI Positioned to Revolutionize Crypto Staking Services
• Mission Produce Takes a Stand Against Illegal Deforestation
• AppLovin Corporation's Exciting Addition to Nasdaq-100 Index
• Explore the Thrilling Closing of the Great Park Live Season
• CompTIA Community Celebrates IT Nation Torch Award Victory
• Investigation into EMCORE Corporation's Acquisition Plans Unveiled
• Stride, Inc. Under Investigation for Potential Securities Claims
• Chipotle Mexican Grill's Shareholders Encouraged to Act Now
• Important Notice: Data Security Incident Update from Forth
• Exploring Pingcheng's Unique Glassware from the Northern Wei
• ThreeD Capital Inc. Expands Stake in AI/ML Innovations Inc.
• Celebrating a Milestone: RVW Wealth's 5th Year in Style
• Exclusive Rare Coin Auction Event Features Historic Collection
• Artisans of Leisure Celebrates Major Travel Industry Awards
• Enhancing Global Shopping Experience for K-Culture Fans
• AEON MINING Revolutionizing Crypto with Innovative Solutions
• Euro Sun Mining Secures First Tranche of Financing in 2024
• Manulife Investment Management Strengthens Global Equity Leadership
• Innovative Trends Driving Energy Drinks Market Expansion
• Pluribus Technologies Corp. Modifies Forbearance Agreement Terms
• Mueller Water Products Engages at 2024 Baird Industrial Conference
• Join the Class Action Lawsuit for Midnight Hub NFT Buyers
• The Mattress Market's Rapid Growth Amid Rising AI Technologies
• Transforming US Dental Care: Market Insights and Growth Trends
• InspireMD's Strategic Inducement Grants: Empowering New Talent
• Spirit Blockchain Capital's Update on Exciting Funding Initiative
• NuLegacy Gold Shares Significant Update on Operations Strategy
• BlackRock Proposes Change for iShares Premium Money Market ETF
• HYTN Innovations Launches Marketing Initiative to Boost Growth
• Rosen Law Firm Investigates Potential Class Action for PACS Group
• Exciting Developments at the ILHA INSPIRE Conference 2024
• Soaring Innovations in the Augmented Reality Market Ahead
• The Future of Long-Term Care: Growth and Trends Ahead